क्यूआर कोड

Rifaximin resistance in Clostridioides difficile is associated with specific rpoB alleles and multilocus sequence typing (MLST) clades

Abstract Background and Objectives Rifaximin (RFX) has recently been suggested as an alternative treatment option for Clostridioides difficile infection. This study reports the survey on RFX susceptibility within a C. difficile test cohort that represents the five clinically relevant phylogenetic cl...

पूर्ण विवरण

में बचाया:
मुख्य लेखकों: Julian Schwanbeck, Friederike Laukien, Thomas Riedel, Boyke Bunk, Philipp Halama, Cathrin Spröer, Jörg Overmann, Paul Cooper, R. Lia Kusumawati, Uwe Groß, Wolfgang Bohne, Andreas E. Zautner
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: BMC 2025-07-01
श्रृंखला:BMC Microbiology
विषय:
Clostridioides difficile
Nosocomial diarrhea
Antibiotic resistance
Rifaximin
Germany
Ghana
ऑनलाइन पहुंच:https://doi.org/10.1186/s12866-025-04164-4
टैग: टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन